Advancing the European bio-based innovation enabled by biotechnology and biomanufacturing concepts

European CommissionFunder

EURegion

€4MBudget

9 daysDeadline

Who can apply

An EU programme, under the Horizon Europe rules of participation. Entities established in the EU and in Associated Countries (the UK included) can lead and be funded. US and other third-country entities can normally join a consortium without receiving EU funding. Two hard exclusions apply programme-wide: entities established in Russia or Belarus are not eligible to participate in any capacity — beneficiary, affiliated entity, associated partner, subcontractor or in-kind third party — and the same bar reaches entities elsewhere that are more than 50% Russian-owned; entities established in China are barred from all Innovation Actions and, unless a call says otherwise, from Research and Innovation Actions, which includes the circular-economy and bio-based topics.

Eligibility rules change between work programmes and individual calls can derogate. This is orientation, not legal advice — confirm against the funder's own conditions before you commit effort.

Call identifier	HORIZON-CL6-2026-01-CIRCBIO-07
Programme	HORIZON-CL6-2026-01
Status	open
Opens	2026-04-17
Closes	2026-09-17
Budget scope	per_project
Deadline, as published	Advancing the European bio-based innovation enabled by biotechnology and biomanufacturing concepts Topic identifier: HORIZON-CL6-2026-01-CIRCBIO-07 Call identifier: HORIZON-CL6-2026-01 Opening date: 2
Verified	2026-08-22

Open the official call page → Find partners & suppliers →

Opens the funder's own publication. Bioecon does not administer this funding and cannot submit on your behalf.

Projected from the funder's publication, which is authoritative. Verify deadline, budget and eligibility before investing time in a proposal.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.